Bayesian predictive probabilities can be used for interim monitoring of clinical trials to estimate the probability of observing a statistically significant treatment effect if the trial were to continue to its predefined maximum sample size. The use of predictive probabilities for interim monitoring is contrasted with alternative strategies such as Bayesian posterior probabilities, p-values, conditional power, and group sequential methods. The benefits of predictive probabilities are discussed in the context of futility and efficacy monitoring, where it is shown that only predictive probabilities properly account for the amount of data remaining to be observed in a clinical trial. -- AudreyCarvajal - 09 Aug 2013

This topic: Main > WebHome > Seminars > BenSavilleSept182013

Topic revision: 13 Aug 2013, AudreyCarvajal

Topic revision: 13 Aug 2013, AudreyCarvajal

Copyright © 2013-2020 by the contributing authors. All material on this collaboration platform is the property of the contributing authors.

Ideas, requests, problems regarding Vanderbilt Biostatistics Wiki? Send feedback

Ideas, requests, problems regarding Vanderbilt Biostatistics Wiki? Send feedback